TISLELIZUMAB

Clinical trials for TISLELIZUMAB explained in plain language.

Never miss a new study

Get alerted when new TISLELIZUMAB trials appear

Sign up with your email to follow new studies for TISLELIZUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 2 Not yet finished but already full! 1 Completed 1

Gut radiation plus immunotherapy may turn inoperable esophageal cancer into a surgical target

Disease control Ongoing

This study tests whether adding a single, low dose of radiation to the small intestine can boost the power of immunotherapy and chemotherapy to shrink esophageal tumors that are too advanced for surgery. About 43 adults with borderline or unresectable esophageal squamous cell car…

Matched conditions: TISLELIZUMAB

Phase: PHASE2 • Sponsor: Chuangzhen Chen • Aim: Disease control

Last updated May 17, 2026 00:40 UTC

TISLELIZUMAB

Get alerted when new TISLELIZUMAB trials appear

Gut radiation plus immunotherapy may turn inoperable esophageal cancer into a surgical target